/NSPR
NSPR Stock - InspireMD, Inc.
Healthcare|Medical - DevicesNASDAQ
$1.64+1.05%
+$0.02 (+1.05%) • Jan 13
64
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.3
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).100
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.91
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+189.6%upside
Target: $4.75
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for NSPR
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$1.62 – $1.66
TARGET (TP)$4.75
STOP LOSS$1.51
RISK/REWARD1:23.9
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta0.72
52W High$3.80
52W Low$1.58
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $7.01M | $6.21M | $5.17M | $4.50M | $2.48M |
| Gross Profit | $1.51M | $1.81M | $1.12M | $754,000 | $83,000 |
| Gross Margin | 21.5% | 29.1% | 21.6% | 16.8% | 3.3% |
| Operating Income | $-33,503,000 | $-21,143,000 | $-18,713,000 | $-14,716,000 | $-10,380,000 |
| Net Income | $-32,005,000 | $-19,916,000 | $-18,491,000 | $-14,918,000 | $-10,544,000 |
| Net Margin | -456.6% | -321.0% | -357.6% | -331.9% | -424.3% |
| EPS | $-0.76 | $-0.82 | $-2.35 | $-2.03 | $-6.90 |
Company Overview
InspireMD, Inc., a medical device company, focuses on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of vascular and coronary diseases in Europe, Latin America, the Middle East, and Asia Pacific. The company offers CGuard carotid embolic prevention system for use in carotid artery applications; and MGuard Prime embolic protection systems for use in patients with acute coronary syndromes, notably acute myocardial infarction, and saphenous vein graft coronary interventions, as well as bypass surgery. It is also developing PVGuard, a MicroNet mesh sleeve and self-expandable stent for use in peripheral vascular applications. The company sells its products through local distributors. InspireMD, Inc. was founded in 2005 and is headquartered in Tel Aviv-Yafo, Israel.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
NSPRBeat Rate
56%
Last 16 quarters
Avg Surprise
-7.9%
EPS vs Estimate
Beats / Misses
9/6
1 met exactly
Latest EPS
$-0.17
Q4 2025
EPS Surprise History
Q1 24
+20.0%
$-0.16vs$-0.20
Q2 24
-40.0%
$-0.21vs$-0.15
Q3 24
-15.8%
$-0.22vs$-0.19
Q4 24
+20.0%
$-0.16vs$-0.20
Q1 25
+5.0%
$-0.19vs$-0.20
Q2 25
-29.4%
$-0.22vs$-0.17
Q3 25
-8.3%
$-0.26vs$-0.24
Q4 25
0.0%
$-0.17vs$-0.17
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | May 7, 2026 | — | — | — | — |
Q1 2026 | Mar 11, 2026 | $-0.22 | — | — | — |
Q4 2025 | Nov 4, 2025 | $-0.17 | $-0.17 | 0.0% | = MET |
Q3 2025 | Aug 4, 2025 | $-0.24 | $-0.26 | -8.3% | ✗ MISS |
Q2 2025 | May 9, 2025 | $-0.17 | $-0.22 | -29.4% | ✗ MISS |
Q1 2025 | Mar 12, 2025 | $-0.20 | $-0.19 | +5.0% | ✓ BEAT |
Q4 2024 | Nov 12, 2024 | $-0.20 | $-0.16 | +20.0% | ✓ BEAT |
Q3 2024 | Aug 6, 2024 | $-0.19 | $-0.22 | -15.8% | ✗ MISS |
Q2 2024 | May 14, 2024 | $-0.15 | $-0.21 | -40.0% | ✗ MISS |
Q1 2024 | Mar 6, 2024 | $-0.20 | $-0.16 | +20.0% | ✓ BEAT |
Q4 2023 | Nov 6, 2023 | $-0.17 | $-0.15 | +11.8% | ✓ BEAT |
Q3 2023 | Aug 8, 2023 | $-0.17 | $-0.24 | -41.2% | ✗ MISS |
Q2 2023 | May 15, 2023 | $-0.68 | $-0.53 | +22.1% | ✓ BEAT |
Q1 2023 | Mar 30, 2023 | $0.84 | $-0.60 | -171.4% | ✗ MISS |
Q4 2022 | Nov 8, 2022 | $-0.73 | $-0.58 | +20.5% | ✓ BEAT |
Q3 2022 | Aug 9, 2022 | $-0.73 | $-0.59 | +19.2% | ✓ BEAT |
Q2 2022 | May 10, 2022 | $-0.80 | $-0.57 | +28.8% | ✓ BEAT |
Q1 2022 | Mar 8, 2022 | $-0.78 | $-0.53 | +32.1% | ✓ BEAT |
Q4 2021 | Nov 9, 2021 | — | $-0.53 | — | — |
Q3 2021 | Aug 10, 2021 | — | $-0.46 | — | — |
Latest News
InspireMD Publishes Data From Its C-GUARDIANS Pivotal Study Journal Of The American College of Cardiology
➖ NeutralBenzinga•Jan 12, 2026, 02:03 PM
InspireMD CREST-2 Data Demonstrates Addition Of Stenting Improves Outcomes In Trial For Participants With Asymptomatic Carotid Stenosis
📈 PositiveBenzinga•Nov 24, 2025, 12:34 PM
InspireMD Q3 EPS $(0.17) Beats $(0.23) Estimate, Sales $2.523M Beat $1.760M Estimate
📈 PositiveBenzinga•Nov 4, 2025, 12:01 PM
InspireMD raises $58M through combined financings; shares up
📈 PositiveSeeking Alpha•Jul 31, 2025, 12:46 PM
Frequently Asked Questions about NSPR
What is NSPR's current stock price?
InspireMD, Inc. (NSPR) is currently trading at $1.64 per share. The stock has moved +1.05% today.
What is the analyst price target for NSPR?
The average analyst price target for NSPR is $4.75, based on 1 analyst.
What sector is InspireMD, Inc. in?
InspireMD, Inc. operates in the Healthcare sector, specifically within the Medical - Devices industry. The company is traded on the NASDAQ exchange.
What is NSPR's market cap?
InspireMD, Inc. has a market capitalization of $0.07 billion, making it a small-cap company.
Does NSPR pay dividends?
No, InspireMD, Inc. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorCNTX
Context Therapeutics Inc.
$1.48
Mkt Cap: $0.1B
EDAP
Edap Tms S.a.
$4.02
Mkt Cap: $0.2B
FONR
FONAR Corporation
$18.59
Mkt Cap: $0.1B
HYPR
Hyperfine, Inc.
$1.06
Mkt Cap: $0.1B
IMA
ImageneBio Inc
$6.86
Mkt Cap: $0.1B
MBOT
Microbot Medical Inc.
$2.10
Mkt Cap: $0.1B
ORMP
Oramed Pharmaceuticals Inc.
$3.58
Mkt Cap: $0.1B
QIPT
Quipt Home Medical Corp.
$3.56
Mkt Cap: $0.2B
RCEL
AVITA Medical, Inc.
$3.32
Mkt Cap: $0.1B
VANI
Vivani Medical, Inc.
$1.29
Mkt Cap: $0.1B
Explore stocks similar to NSPR for comparison